Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market
Bloomberg Talks · Bloomberg
July 30, 20257m 7s
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.
See omnystudio.com/listener for privacy information.